Borca, M.V.; Ramirez-Medina, E.; Silva, E.; Rai, A.; Espinoza, N.; Velazquez-Salinas, L.; Gladue, D.P.
ASF Vaccine Candidate ASFV-G-∆I177L Does Not Exhibit Residual Virulence in Long-Term Clinical Studies. Pathogens 2023, 12, 805.
https://doi.org/10.3390/pathogens12060805
AMA Style
Borca MV, Ramirez-Medina E, Silva E, Rai A, Espinoza N, Velazquez-Salinas L, Gladue DP.
ASF Vaccine Candidate ASFV-G-∆I177L Does Not Exhibit Residual Virulence in Long-Term Clinical Studies. Pathogens. 2023; 12(6):805.
https://doi.org/10.3390/pathogens12060805
Chicago/Turabian Style
Borca, Manuel V., Elizabeth Ramirez-Medina, Ediane Silva, Ayushi Rai, Nallely Espinoza, Lauro Velazquez-Salinas, and Douglas P. Gladue.
2023. "ASF Vaccine Candidate ASFV-G-∆I177L Does Not Exhibit Residual Virulence in Long-Term Clinical Studies" Pathogens 12, no. 6: 805.
https://doi.org/10.3390/pathogens12060805
APA Style
Borca, M. V., Ramirez-Medina, E., Silva, E., Rai, A., Espinoza, N., Velazquez-Salinas, L., & Gladue, D. P.
(2023). ASF Vaccine Candidate ASFV-G-∆I177L Does Not Exhibit Residual Virulence in Long-Term Clinical Studies. Pathogens, 12(6), 805.
https://doi.org/10.3390/pathogens12060805